Stock Track | Embecta Plunges 7.79% Pre-Market on Q4 Earnings Miss and Weak Outlook

Stock Track11-25

Embecta Corp. (EMBC) shares tumbled 7.79% in pre-market trading on Tuesday after the diabetes care company reported fourth-quarter results that fell short of analyst expectations and provided a cautious outlook for fiscal 2026.

For the fourth quarter, Embecta posted revenue of $264 million, down 7.7% year-over-year and below the consensus estimate of $265.7 million. Adjusted earnings per share came in at $0.50, missing the expected $0.54. The company attributed the revenue decline to several factors, including the impact of advanced distributor ordering in previous quarters and ongoing business challenges in China.

Looking ahead, Embecta provided initial guidance for fiscal 2026, projecting revenue between $1.071 billion and $1.093 billion, and adjusted earnings per share in the range of $2.80 to $3.00. While the revenue forecast aligns with analyst expectations, the earnings outlook suggests potential headwinds. The company also anticipates an adjusted operating margin of 29% to 30% for the year.

Despite the disappointing results, Embecta highlighted its progress in debt reduction and operational efficiency. The company reduced its debt by approximately $184.5 million in fiscal 2025, exceeding its original target. However, investors appear to be focusing on the near-term challenges and uncertain growth prospects, leading to the significant pre-market sell-off.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157344054?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-25 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157344054","market":"nz","top_or_hot":-1,"title":"Stock Track | Embecta Plunges 7.79% Pre-Market on Q4 Earnings Miss and Weak Outlook","media":"Stock Track","content":"<p>Embecta Corp. (EMBC) shares tumbled 7.79% in pre-market trading on Tuesday after the diabetes care company reported fourth-quarter results that fell short of analyst expectations and provided a cautious outlook for fiscal 2026.</p>\n\n<p>For the fourth quarter, Embecta posted revenue of $264 million, down 7.7% year-over-year and below the consensus estimate of $265.7 million. Adjusted earnings per share came in at $0.50, missing the expected $0.54. The company attributed the revenue decline to several factors, including the impact of advanced distributor ordering in previous quarters and ongoing business challenges in China.</p>\n\n<p>Looking ahead, Embecta provided initial guidance for fiscal 2026, projecting revenue between $1.071 billion and $1.093 billion, and adjusted earnings per share in the range of $2.80 to $3.00. While the revenue forecast aligns with analyst expectations, the earnings outlook suggests potential headwinds. The company also anticipates an adjusted operating margin of 29% to 30% for the year.</p>\n\n<p>Despite the disappointing results, Embecta highlighted its progress in debt reduction and operational efficiency. The company reduced its debt by approximately $184.5 million in fiscal 2025, exceeding its original target. However, investors appear to be focusing on the near-term challenges and uncertain growth prospects, leading to the significant pre-market sell-off.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Embecta Plunges 7.79% Pre-Market on Q4 Earnings Miss and Weak Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Embecta Plunges 7.79% Pre-Market on Q4 Earnings Miss and Weak Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-25 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Embecta Corp. (EMBC) shares tumbled 7.79% in pre-market trading on Tuesday after the diabetes care company reported fourth-quarter results that fell short of analyst expectations and provided a cautious outlook for fiscal 2026.</p>\n\n<p>For the fourth quarter, Embecta posted revenue of $264 million, down 7.7% year-over-year and below the consensus estimate of $265.7 million. Adjusted earnings per share came in at $0.50, missing the expected $0.54. The company attributed the revenue decline to several factors, including the impact of advanced distributor ordering in previous quarters and ongoing business challenges in China.</p>\n\n<p>Looking ahead, Embecta provided initial guidance for fiscal 2026, projecting revenue between $1.071 billion and $1.093 billion, and adjusted earnings per share in the range of $2.80 to $3.00. While the revenue forecast aligns with analyst expectations, the earnings outlook suggests potential headwinds. The company also anticipates an adjusted operating margin of 29% to 30% for the year.</p>\n\n<p>Despite the disappointing results, Embecta highlighted its progress in debt reduction and operational efficiency. The company reduced its debt by approximately $184.5 million in fiscal 2025, exceeding its original target. However, investors appear to be focusing on the near-term challenges and uncertain growth prospects, leading to the significant pre-market sell-off.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EMBC","symbol_name":"Embecta Corp.","start_time":0,"source_url":"","article_id":"1157344054","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157344054","pubTimestamp":1764075753,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Embecta Corp. (EMBC) shares tumbled 7.79% in pre-market trading on Tuesday after the diabetes care company reported fourth-quarter results that fell short of analyst expectations and provided a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EMBC":"Embecta Corp."},"translate_title":"个股追踪|Embecta盘前暴跌7.79%，因第四季度盈利未达预期且前景疲弱","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMBC":1},"content_text":"Embecta Corp. (EMBC) shares tumbled 7.79% in pre-market trading on Tuesday after the diabetes care company reported fourth-quarter results that fell short of analyst expectations and provided a cautious outlook for fiscal 2026.\nFor the fourth quarter, Embecta posted revenue of $264 million, down 7.7% year-over-year and below the consensus estimate of $265.7 million. Adjusted earnings per share came in at $0.50, missing the expected $0.54. The company attributed the revenue decline to several factors, including the impact of advanced distributor ordering in previous quarters and ongoing business challenges in China.\nLooking ahead, Embecta provided initial guidance for fiscal 2026, projecting revenue between $1.071 billion and $1.093 billion, and adjusted earnings per share in the range of $2.80 to $3.00. While the revenue forecast aligns with analyst expectations, the earnings outlook suggests potential headwinds. The company also anticipates an adjusted operating margin of 29% to 30% for the year.\nDespite the disappointing results, Embecta highlighted its progress in debt reduction and operational efficiency. The company reduced its debt by approximately $184.5 million in fiscal 2025, exceeding its original target. However, investors appear to be focusing on the near-term challenges and uncertain growth prospects, leading to the significant pre-market sell-off.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157344054","isCrawlerRequest":true}